Loss of heterozygosities in Barrett esophagus, dysplasia, and adenocarcinoma detected by esophageal brushing cytology and gastroesophageal biopsy

Xiaoqi Lin*, Sydney D. Finkelstein, Bing Zhu, Beth J. Ujevich, Jan F. Silverman

*Corresponding author for this work

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

BACKGROUND: Esophageal brushing cytology (EBC) and gastroesophageal biopsy (GEB) are complementary procedures for the evaluation of gastroesophageal lesions that help guide surveillance and treatment. METHODS: The authors investigated loss of heterozygosity (LOH) of 17 microsatellite repeat markers near tumor suppressor genes in gastroesophageal lesions on 34 concomitant EBCs and GEBs. RESULTS: The results indicated that there was progressive accumulation of LOHs toward malignant transformation. EBC samples a greater area than GEB, and more LOHs are detected by EBC than GEB. The combination of cytomorphology and detection of LOHs can improve diagnostic accuracy and is a more useful methodology with which to evaluate gastroesophageal lesions than either EBC or GEB alone. The authors also found that LOHs at 1p36, 9p21, and 17p13 may play an important role in Barrett esophagus (BE), LOHs at 10q23, 17p13, and 17q12 in low-grade dysplasia (LGD), LOHs at 5q23 and 17q21 in high-grade dysplasia (HGD), and LOHs at 5q23 and 21q22 in adenocarcinoma. CONCLUSIONS: Detection of LOHs targeting tumor suppressor genes can be useful in evaluating gastroesophageal lesions, studying oncogenesis of gastroesophageal adenocarcinoma, and, in combination with EBC and GEB, determining surveillance for BE and LGD and/or treatment for HGD and adenocarcinoma.

Original languageEnglish (US)
Pages (from-to)57-66
Number of pages10
JournalCancer Cytopathology
Volume117
Issue number1
DOIs
StatePublished - Dec 1 2009

Fingerprint

Barrett Esophagus
Loss of Heterozygosity
Cell Biology
Adenocarcinoma
Biopsy
Tumor Suppressor Genes
Microsatellite Repeats
Carcinogenesis
Therapeutics

Keywords

  • Adenocarcinoma
  • Barrett esophagus
  • Dysplasia
  • Esophageal brushing cytology
  • Gastroesophageal biopsy
  • Loss of heterozygosity

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Lin, Xiaoqi ; Finkelstein, Sydney D. ; Zhu, Bing ; Ujevich, Beth J. ; Silverman, Jan F. / Loss of heterozygosities in Barrett esophagus, dysplasia, and adenocarcinoma detected by esophageal brushing cytology and gastroesophageal biopsy. In: Cancer Cytopathology. 2009 ; Vol. 117, No. 1. pp. 57-66.
@article{4ff1953f134842108e0d6783474ec443,
title = "Loss of heterozygosities in Barrett esophagus, dysplasia, and adenocarcinoma detected by esophageal brushing cytology and gastroesophageal biopsy",
abstract = "BACKGROUND: Esophageal brushing cytology (EBC) and gastroesophageal biopsy (GEB) are complementary procedures for the evaluation of gastroesophageal lesions that help guide surveillance and treatment. METHODS: The authors investigated loss of heterozygosity (LOH) of 17 microsatellite repeat markers near tumor suppressor genes in gastroesophageal lesions on 34 concomitant EBCs and GEBs. RESULTS: The results indicated that there was progressive accumulation of LOHs toward malignant transformation. EBC samples a greater area than GEB, and more LOHs are detected by EBC than GEB. The combination of cytomorphology and detection of LOHs can improve diagnostic accuracy and is a more useful methodology with which to evaluate gastroesophageal lesions than either EBC or GEB alone. The authors also found that LOHs at 1p36, 9p21, and 17p13 may play an important role in Barrett esophagus (BE), LOHs at 10q23, 17p13, and 17q12 in low-grade dysplasia (LGD), LOHs at 5q23 and 17q21 in high-grade dysplasia (HGD), and LOHs at 5q23 and 21q22 in adenocarcinoma. CONCLUSIONS: Detection of LOHs targeting tumor suppressor genes can be useful in evaluating gastroesophageal lesions, studying oncogenesis of gastroesophageal adenocarcinoma, and, in combination with EBC and GEB, determining surveillance for BE and LGD and/or treatment for HGD and adenocarcinoma.",
keywords = "Adenocarcinoma, Barrett esophagus, Dysplasia, Esophageal brushing cytology, Gastroesophageal biopsy, Loss of heterozygosity",
author = "Xiaoqi Lin and Finkelstein, {Sydney D.} and Bing Zhu and Ujevich, {Beth J.} and Silverman, {Jan F.}",
year = "2009",
month = "12",
day = "1",
doi = "10.1002/cncy.20010",
language = "English (US)",
volume = "117",
pages = "57--66",
journal = "Cancer cytopathology",
issn = "1934-662X",
publisher = "Wiley-Blackwell",
number = "1",

}

Loss of heterozygosities in Barrett esophagus, dysplasia, and adenocarcinoma detected by esophageal brushing cytology and gastroesophageal biopsy. / Lin, Xiaoqi; Finkelstein, Sydney D.; Zhu, Bing; Ujevich, Beth J.; Silverman, Jan F.

In: Cancer Cytopathology, Vol. 117, No. 1, 01.12.2009, p. 57-66.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Loss of heterozygosities in Barrett esophagus, dysplasia, and adenocarcinoma detected by esophageal brushing cytology and gastroesophageal biopsy

AU - Lin, Xiaoqi

AU - Finkelstein, Sydney D.

AU - Zhu, Bing

AU - Ujevich, Beth J.

AU - Silverman, Jan F.

PY - 2009/12/1

Y1 - 2009/12/1

N2 - BACKGROUND: Esophageal brushing cytology (EBC) and gastroesophageal biopsy (GEB) are complementary procedures for the evaluation of gastroesophageal lesions that help guide surveillance and treatment. METHODS: The authors investigated loss of heterozygosity (LOH) of 17 microsatellite repeat markers near tumor suppressor genes in gastroesophageal lesions on 34 concomitant EBCs and GEBs. RESULTS: The results indicated that there was progressive accumulation of LOHs toward malignant transformation. EBC samples a greater area than GEB, and more LOHs are detected by EBC than GEB. The combination of cytomorphology and detection of LOHs can improve diagnostic accuracy and is a more useful methodology with which to evaluate gastroesophageal lesions than either EBC or GEB alone. The authors also found that LOHs at 1p36, 9p21, and 17p13 may play an important role in Barrett esophagus (BE), LOHs at 10q23, 17p13, and 17q12 in low-grade dysplasia (LGD), LOHs at 5q23 and 17q21 in high-grade dysplasia (HGD), and LOHs at 5q23 and 21q22 in adenocarcinoma. CONCLUSIONS: Detection of LOHs targeting tumor suppressor genes can be useful in evaluating gastroesophageal lesions, studying oncogenesis of gastroesophageal adenocarcinoma, and, in combination with EBC and GEB, determining surveillance for BE and LGD and/or treatment for HGD and adenocarcinoma.

AB - BACKGROUND: Esophageal brushing cytology (EBC) and gastroesophageal biopsy (GEB) are complementary procedures for the evaluation of gastroesophageal lesions that help guide surveillance and treatment. METHODS: The authors investigated loss of heterozygosity (LOH) of 17 microsatellite repeat markers near tumor suppressor genes in gastroesophageal lesions on 34 concomitant EBCs and GEBs. RESULTS: The results indicated that there was progressive accumulation of LOHs toward malignant transformation. EBC samples a greater area than GEB, and more LOHs are detected by EBC than GEB. The combination of cytomorphology and detection of LOHs can improve diagnostic accuracy and is a more useful methodology with which to evaluate gastroesophageal lesions than either EBC or GEB alone. The authors also found that LOHs at 1p36, 9p21, and 17p13 may play an important role in Barrett esophagus (BE), LOHs at 10q23, 17p13, and 17q12 in low-grade dysplasia (LGD), LOHs at 5q23 and 17q21 in high-grade dysplasia (HGD), and LOHs at 5q23 and 21q22 in adenocarcinoma. CONCLUSIONS: Detection of LOHs targeting tumor suppressor genes can be useful in evaluating gastroesophageal lesions, studying oncogenesis of gastroesophageal adenocarcinoma, and, in combination with EBC and GEB, determining surveillance for BE and LGD and/or treatment for HGD and adenocarcinoma.

KW - Adenocarcinoma

KW - Barrett esophagus

KW - Dysplasia

KW - Esophageal brushing cytology

KW - Gastroesophageal biopsy

KW - Loss of heterozygosity

UR - http://www.scopus.com/inward/record.url?scp=65349128872&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65349128872&partnerID=8YFLogxK

U2 - 10.1002/cncy.20010

DO - 10.1002/cncy.20010

M3 - Article

C2 - 19347831

AN - SCOPUS:65349128872

VL - 117

SP - 57

EP - 66

JO - Cancer cytopathology

JF - Cancer cytopathology

SN - 1934-662X

IS - 1

ER -